dr shallis on the utility of luspatercept in the element-mds trial in mds
Published 1 month ago • 40 plays • Length 3:44Download video MP4
Download video MP3
Similar videos
-
0:44
dr. patel on the clinical implications of luspatercept approval in mds
-
1:31
overall survival of patients following treatment with luspatercept in the medalist trial
-
1:38
novel treatment options for lr-mds and the importance of clinical trials in this space
-
4:48
alan list: is luspatercept a new option for patients with mds?
-
2:12
improving the treatment of low-risk mds: luspatercept, treatment sequencing & disease classification
-
1:54
what is the future role of luspatercept in patients with low-risk md
-
1:38
phase ii trial of luspatercept in myelofibrosis-associated anemia
-
4:17
mds clinical trials: the european effort
-
4:12
novel therapies in low-risk mds
-
4:25
the challenges with accurately diagnosing and risk-stratifying patients with mds
-
1:39
luspatercept - clinical trial update
-
2:18
dr. snyder on the quest to revolutionize management of myelofibrosis
-
6:09
selution slr technology – why sustained limus release matters presented by john shulze
-
6:55
panel shares thoughts on luspatercept for mds and future research needs for this therapy
-
3:19
sheild-rt: implementing machine learning in the clinic
-
1:20
meet susan ovella, md - internal medicine, pediatrics - our lady of the lake physician group
-
2:29
optimal prehospital crystalloid volume
-
9:49
companies to watch - salutarismd (ois@aao 2016)
-
8:50
safety of cytoreductive surgery with hipec for recurrent uterine leiomyosarcoma